We are live on ! Find out more
SG

StoneX Group Portfolio holdings

AUM $1.86B
1-Year Est. Return 21.3%
This Fund
S&P 500
This Quarter Est. Return
+2.28%
1 Year Est. Return
+21.3%
3 Year Est. Return
+67.54%
5 Year Est. Return
+78.7%
10 Year Est. Return
AUM
$2.3B
AUM Growth
+$10.4M
Cap. Flow
-$19.8M
Cap. Flow %
-0.86%
Top 10 Hldgs %
28.74%
Holding
1,257
New
327
Increased
411
Reduced
331
Closed
170

Sector Composition

Rank Sector Weight
1 Technology 9.8%
2 Financials 5.32%
3 Healthcare 3.19%
4 Industrials 3.18%
5 Consumer Discretionary 3.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PROP icon
951
Prairie Operating Co
PROP
$78.2M
$32.3K ﹤0.01%
+19,119
New +$34.7K
DNN icon
952
Denison Mines
DNN
$2.63B
$32.1K ﹤0.01%
12,073
-1,975
-14% -$5.37K
GLDG
953
GoldMining Inc
GLDG
$179M
$31.5K ﹤0.01%
25,210
GAU
954
Galiano Gold
GAU
$486M
$30.4K ﹤0.01%
12,000
CNVS icon
955
Cineverse
CNVS
$55M
$30.1K ﹤0.01%
+14,273
New +$38.7K
OGI
956
Organigram Holdings
OGI
$132M
$29.6K ﹤0.01%
+17,616
New +$30.3K
OXSQ icon
957
Oxford Square Capital
OXSQ
$151M
$28.8K ﹤0.01%
+16,359
New +$29.8K
WTI icon
958
W&T Offshore
WTI
$545M
$27.6K ﹤0.01%
+16,918
New +$32.5K
RPTX
959
DELISTED
Repare Therapeutics
RPTX
$27.6K ﹤0.01%
+10,603
New +$21.3K
OPK icon
960
Opko Health
OPK
$921M
$27.2K ﹤0.01%
+21,599
New +$30.1K
SATL icon
961
Satellogic
SATL
$532M
$25.2K ﹤0.01%
+13,452
New +$29.1K
MNOV icon
962
MediciNova
MNOV
$65M
$25.2K ﹤0.01%
+19,200
New +$26.5K
HRTX icon
963
Heron Therapeutics
HRTX
$86.3M
$24.5K ﹤0.01%
+18,809
New +$23.2K
BEAGR
964
Bold Eagle Acquisition Corp Right
BEAGR
$24.1K ﹤0.01%
75,348
-51,070
-40% -$18K
MBOT icon
965
Microbot Medical
MBOT
$115M
$24.1K ﹤0.01%
+12,046
New +$28.5K
STIM icon
966
Neuronetics
STIM
$120M
$23.3K ﹤0.01%
+16,917
New +$35.4K
PRSO icon
967
Peraso
PRSO
$10.3M
$22.6K ﹤0.01%
+25,951
New +$30.5K
SNDL icon
968
Sundial Growers
SNDL
$324M
$22.2K ﹤0.01%
+13,376
New +$26.8K
BGLWW
969
Blue Gold Ltd Warrant
BGLWW
$914K
$20.9K ﹤0.01%
49,600
-10,400
-17% -$5.57K
PHUN icon
970
Phunware
PHUN
$44M
$20.5K ﹤0.01%
+11,065
New +$25.7K
ALLO icon
971
Allogene Therapeutics
ALLO
$601M
$20.4K ﹤0.01%
+14,867
New +$19.6K
HYFT
972
MindWalk Holdings
HYFT
$63.5M
$19.9K ﹤0.01%
+10,926
New +$19.2K
DRDBW
973
Roman DBDR Acquisition Corp II Warrants
DRDBW
$19.3K ﹤0.01%
+33,921
New +$22.3K
CIF
974
DELISTED
MFS Intermediate High Income Fund
CIF
$19.3K ﹤0.01%
+11,367
New +$19.7K
LXRX icon
975
Lexicon Pharmaceuticals
LXRX
$1.02B
$18.7K ﹤0.01%
+16,234
New +$22.3K

Similar funds

StoneX Group's Q4 2025 Portfolio in Review

As of Q4 2025, StoneX Group held 1,257 positions worth $2.3B, up 0.45% from $2.29B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

StoneX Group's Q4 2025 filing shows 327 new, 411 increased, 331 reduced and 170 closed positions. Its largest new stake was VictoryShares International Value Momentum ETF: 92,238 shares worth $5.95M. The largest sale was NetEase, an estimated $21.8M.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, down from 9.9% a quarter earlier, followed by Financials and Healthcare.

  • StoneX Group's largest Q4 2025 buy was VictoryShares International Value Momentum ETF: 92,238 shares worth $5.95M.
  • StoneX Group added most to JPMorgan Active Bond ETF in Q4 2025, an estimated $39M increase.
  • StoneX Group's biggest Q4 2025 reduction was Invesco QQQ Trust, cutting an estimated $10.4M.
  • StoneX Group fully exited NetEase in Q4 2025, selling an estimated $21.8M.
  • StoneX Group's ten largest holdings make up 29% of its $2.3B portfolio in Q4 2025.
  • StoneX Group opened 327 new positions and closed 170 in Q4 2025.
  • StoneX Group's portfolio value rose 0.45% quarter-over-quarter to $2.3B.

Based on StoneX Group's 13F filing for Q4 2025, filed 12 Feb 2026.